148 related articles for article (PubMed ID: 15770430)
1. The p38 MAPK inhibitor SB203580 blocks adenosine A(1) receptor-induced attenuation of in vivo myocardial stunning.
Yoshimura Y; Kristo G; Keith BJ; Jahania SA; Mentzer RM; Lasley RD
Cardiovasc Drugs Ther; 2004 Nov; 18(6):433-40. PubMed ID: 15770430
[TBL] [Abstract][Full Text] [Related]
2. Adenosine A1/A2a receptor agonist AMP-579 induces acute and delayed preconditioning against in vivo myocardial stunning.
Kristo G; Yoshimura Y; Keith BJ; Stevens RM; Jahania SA; Mentzer RM; Lasley RD
Am J Physiol Heart Circ Physiol; 2004 Dec; 287(6):H2746-53. PubMed ID: 15271662
[TBL] [Abstract][Full Text] [Related]
3. Ischemic preconditioning does not acutely improve load-insensitive parameters of contractility in in vivo stunned porcine myocardium.
Jahania MS; Lasley RD; Mentzer RM
J Thorac Cardiovasc Surg; 1999 Apr; 117(4):810-7. PubMed ID: 10096978
[TBL] [Abstract][Full Text] [Related]
4. Milrinone and levosimendan administered after reperfusion improve myocardial stunning in swine.
Shibata I; Cho S; Yoshitomi O; Ureshino H; Maekawa T; Hara T; Sumikawa K
Scand Cardiovasc J Suppl; 2013 Feb; 47(1):50-7. PubMed ID: 22994851
[TBL] [Abstract][Full Text] [Related]
5. Sodium-hydrogen exchange inhibition attenuates in vivo porcine myocardial stunning.
Stevens RM; Salik Jahania M; Mentzer RM; Lasley RD
Ann Thorac Surg; 2004 Feb; 77(2):651-7. PubMed ID: 14759454
[TBL] [Abstract][Full Text] [Related]
6. The intermediary metabolite pyruvate attenuates stunning and reduces infarct size in in vivo porcine myocardium.
Kristo G; Yoshimura Y; Niu J; Keith BJ; Mentzer RM; Bünger R; Lasley RD
Am J Physiol Heart Circ Physiol; 2004 Feb; 286(2):H517-24. PubMed ID: 14551043
[TBL] [Abstract][Full Text] [Related]
7. p38 mitogen-activated protein kinase inhibition decreases TNFalpha secretion and protects against left ventricular remodeling in rats with myocardial ischemia.
Yin H; Zhang J; Lin H; Wang R; Qiao Y; Wang B; Liu F
Inflammation; 2008 Apr; 31(2):65-73. PubMed ID: 17943427
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of p38 MAPK activation protects cardiac mitochondria from ischemia/reperfusion injury.
Kumphune S; Surinkaew S; Chattipakorn SC; Chattipakorn N
Pharm Biol; 2015; 53(12):1831-41. PubMed ID: 25880145
[TBL] [Abstract][Full Text] [Related]
9. The p38 MAPK inhibitor, SB203580, abrogates ischaemic preconditioning in rat heart but timing of administration is critical.
Mocanu MM; Baxter GF; Yue Y; Critz SD; Yellon DM
Basic Res Cardiol; 2000 Dec; 95(6):472-8. PubMed ID: 11192368
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of p38 MAPK during ischemia, but not reperfusion, effectively attenuates fatal arrhythmia in ischemia/reperfusion heart.
Surinkaew S; Kumphune S; Chattipakorn S; Chattipakorn N
J Cardiovasc Pharmacol; 2013 Feb; 61(2):133-41. PubMed ID: 23107875
[TBL] [Abstract][Full Text] [Related]
11. Limitation of myocardial reperfusion injury by AMP579, an adenosine A1/A2A receptor agonist: role of A2A receptor and Erk1/2.
Kis A; Baxter GF; Yellon DM
Cardiovasc Drugs Ther; 2003; 17(5-6):415-25. PubMed ID: 15107596
[TBL] [Abstract][Full Text] [Related]
12. Acute adenosine preconditioning is mediated by p38 MAPK activation in discrete subcellular compartments.
Ballard-Croft C; Kristo G; Yoshimura Y; Reid E; Keith BJ; Mentzer RM; Lasley RD
Am J Physiol Heart Circ Physiol; 2005 Mar; 288(3):H1359-66. PubMed ID: 15539417
[TBL] [Abstract][Full Text] [Related]
13. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction.
Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL
J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911
[TBL] [Abstract][Full Text] [Related]
14. Coronary microembolization induced myocardial contractile dysfunction and tumor necrosis factor-α mRNA expression partly inhibited by SB203580 through a p38 mitogen-activated protein kinase pathway.
Li L; Qu N; Li DH; Wen WM; Huang WQ
Chin Med J (Engl); 2011 Jan; 124(1):100-5. PubMed ID: 21362316
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of p38 MAPK and AMPK restores adenosine-induced cardioprotection in hearts stressed by antecedent ischemia by altering glucose utilization.
Jaswal JS; Gandhi M; Finegan BA; Dyck JR; Clanachan AS
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1107-14. PubMed ID: 17496214
[TBL] [Abstract][Full Text] [Related]
16. Role of p38-mitogen-activated protein kinase in ischaemic preconditioning in rat heart.
Bell JR; Eaton P; Shattock MJ
Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):126-34. PubMed ID: 17892505
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of adenosine A(2a) agonist CGS-21680 in infarcted and stunned porcine myocardium.
Lasley RD; Jahania MS; Mentzer RM
Am J Physiol Heart Circ Physiol; 2001 Apr; 280(4):H1660-6. PubMed ID: 11247777
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the cardiac p38-MAPK pathway by SB203580 delays ischemic cell death.
Barancik M; Htun P; Strohm C; Kilian S; Schaper W
J Cardiovasc Pharmacol; 2000 Mar; 35(3):474-83. PubMed ID: 10710135
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of p38 MAPK activity fails to attenuate contractile dysfunction in a mouse model of low-flow ischemia.
Gorog DA; Tanno M; Cao X; Bellahcene M; Bassi R; Kabir AM; Dighe K; Quinlan RA; Marber MS
Cardiovasc Res; 2004 Jan; 61(1):123-31. PubMed ID: 14732209
[TBL] [Abstract][Full Text] [Related]
20. Effects of adenosine and acadesine on interstitial nucleosides and myocardial stunning in the pig.
Lasley RD; Randhawa MP; Hegge JO; Mentzer RM
Can J Physiol Pharmacol; 1999 Apr; 77(4):259-67. PubMed ID: 10535674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
